Chronic insomnia disorder, which affects 6–10% of the population, is diagnostically
characterized by ongoing difficulties with initiating or maintaining sleep occurring at least …

Insomnia is the most common sleep disorder characterized by nocturnal symptoms;
difficulties initiating or maintaining sleep; and daytime symptoms, such as difficulty with …

OBJECTIVE: Insomnia has high prevalence rates and is associated with significant personal
and socioeconomic burden, yet it remains largely underrecognized and inadequately …

Advances in understanding the neurochemistry of sleep and waking have stimulated new
pharmacological directions in the treatment of insomnia. While the sedation of historic …

Several different types of medications are currently available for the treatment of insomnia.
These agents include:(1) a group approved by the US Food and Drug Administration (FDA) …

Insomnia disorder affects a large proportion of the population on a situational, recurrent or
chronic basis and is among the most common complaints in medical practice. The disorder …

Insomnia is the most common sleep disorder in the industrialized world. A variety of
precipitating events have been identified, but when it becomes a persistent problem …

Insomnia, defined by difficulty falling asleep or remaining asleep, early morning awakening
and/or non-restorative sleep, and daytime consequences, is an important public health issue …

The first source on insomnia treatment since the advancement of newer drug options and
cognitive behavioral therapies, Insomnia: Diagnosis and Treatment presents a …

Background. Despite the high prevalence and the high burden associated with chronic
insomnia, it remains largely unrecognized and often inadequately treated by physicians …